-
PTI Announces Acquisition of Leak Detection Associates
americanpharmaceuticalreview
December 03, 2020
PTI (Packaging Technologies & Inspection) announced the completion of its acquisition of Leak Detection Associates (LDA), a manufacturer of helium-based, high sensitivity leak detection systems for the pharmaceutical and biologic industries.
-
Bora Pharmaceuticals completes acquisition of former GSK facility
prnasia
December 02, 2020
Bora Pharmaceuticals Co., Ltd announced that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK's Mississauga, Ontario (Canada) facility.
-
Covis Group Completes Acquisition of AMAG Pharmaceuticals
prnasia
November 17, 2020
Covis Group S.à r.l. announced the completion of its acquisition of AMAG Pharmaceuticals, Inc. through the successful tender offer for all of the outstanding shares of common stock of AMAG at $13.75 per share in cash and subsequent merger.
-
Antares Vision Acquires Adents Traceability Assets
contractpharma
November 16, 2020
Antares Vision has purchased the assets of the French company Adents High Tech International in a transaction valued at €1.5 million.
-
Novo Nordisk set to acquire Emisphere for $1.8 billion
europeanpharmaceuticalreview
November 13, 2020
Following approval by Emisphere shareholders, Novo Nordisk will acquire the company for a total of $1.8 billion.
-
Pharmaron acquires Absorption Systems in US
pharmaceutical-business-review
November 11, 2020
Pharmaron Beijing announced that it has acquired 100% of the equity of Absorption Systems for up to $137.5m in cash.
-
Applied Materials Acquires Perceptive Engineering
PharmaSources.com
November 11, 2020
Applied Materials has acquired Perceptive Engineering Ltd., headquartered in Manchester, UK, a leader in advanced process control and model predictive control in the pharmaceutical industry.
-
PerkinElmer to Acquire Cell Engineering Company Horizon Discovery
americanpharmaceuticalreview
November 06, 2020
PerkinElmer and Horizon Discovery Group have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire Horizon for approximately $383 million (£296 million).
-
Aurobindo Pharma to divest Natrol to New Mountain Capit
expresspharma
October 28, 2020
Aurobindo Pharma has reached a definitive agreement to sell Natrol, a wholly owned subsidiary of Aurobindo Pharma US, to an affiliate of New Mountain Capital to combine with Jarrow Formulas.
-
Gilead Sciences acquires Immunomedics in $21bn deal
pharmaceutical-technology
October 28, 2020
Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn.